Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy (Q42658687)
Jump to navigation
Jump to search
scientific article published on June 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy |
scientific article published on June 1997 |
Statements
1 reference
Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy (English)
1 reference
Trouillas P
1 reference
Xie J
1 reference
Adeleine P
1 reference
Michel D
1 reference
Vighetto A
1 reference
Honnorat J
1 reference
Dumas R
1 reference
Nighoghossian N
1 reference
Laurent B
1 reference
1 June 1997
1 reference
1 reference
54
1 reference
6
1 reference
749-752
1 reference
Identifiers
1 reference
1 reference